XY Planning Network’s Vertex Pharmaceuticals VRTX Stock Holding History

XY Planning Network’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$373K	Buy	+751	New	+$333K	0.05%	249

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

XY Planning Network's VRTX Position: Q2 2026 in Review

XY Planning Network opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 751 shares worth $373K. The stake represents 0.05% of the portfolio and ranks #249 among its holdings.

484 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

XY Planning Network held 751 shares of Vertex Pharmaceuticals worth $373K as of Q2 2026.
Vertex Pharmaceuticals was a new XY Planning Network position in Q2 2026.
Vertex Pharmaceuticals made up 0.05% of XY Planning Network's portfolio in Q2 2026, its #249 holding.
484 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on XY Planning Network's 13F filing for Q2 2026, filed 15 Jul 2026.